News & Events

News, industry insights and noteworthy events.

At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.

For media or press inquiries, please email us.

Contact Us

  1. Tanner Pharma Plants 9,175 Trees in the UK in Partnership with Treeapp

    Tanner x Treeapp Tanner and Treeapp have been working together since February 2022. In that time we have planted 9,175 trees together in the UK, at the Treeapp site in Llangoedmor in West Wales (more info here). Prior to intervention, this land was degraded forest. 16 different species were planted here, the most prominent being…

    Read More
  2. Overcoming procurement and supply chain challenges in clinical trials

    Originally posted on Pharmaceutical Technology. The global pandemic has had a significant impact on clinical trials, forcing operators to alter their processes. Tanner Pharma’s Clinical Trial Services (TannerCTS) division has been working to overcome challenges with procurement and ensure supply continuity, while looking to the future by embracing technological innovations. To discover more, we talk…

    Read More
  3. Hispanic Heritage Month 2022

    Hispanic Heritage Month runs from September 15 – October 15 and recognizes the cultures, histories, achievements and contributions of Hispanic Americans. Unlike many monthly observances, Hispanic Heritage Month begins in the middle rather than the start of September. This is because it coincides with the national independence days of several Latin American countries including Costa Rica,…

    Read More
  4. Building a global supply chain network for clinical trial products

    Originally posted on Pharmaceutical Technology. On-time deliveries are paramount in the pharmaceutical world. But ensuring expedited transfer from one location to another is only a piece of the process. Packaging requirements, temperature controls, country-specific transport and storage capabilities, and more must be strictly managed to ensure success. Tanner Pharma Group has established a specialist storage…

    Read More
  5. Protection through preparation: How self-test kits became essential

    Originally posted on Pharmaceutical Technology. The value of self-test kits has surged in the last two years and these items are now viewed as an integral part of the fight against a rise of infectious diseases, from Covid-19 to monkeypox. We learn how Tanner’s GMS division ensures sufficient supply as demand increases. Self-test kits have…

    Read More
  6. Tanner Pharma Group Supports Ukraine

    In response to the ongoing crisis in Ukraine, Tanner Pharma Group will contribute over $124,500 and donate 14,803 units of essential products to select organizations that are making a positive impact and actively providing direct aid and relief to those most affected by Russia’s war in Ukraine. Learn more about the work of these organizations…

    Read More
  7. Tanner Pharma is a Finalist in the Supply Chain Excellence Awards 2022

    Tanner Pharma Group will be considered in two categories as part of the the Supply Chain Excellence Awards 2022 alongside partners Akeso & Company and Kuehne+Nagel for their collaborative efforts supporting immediate COVID response. Learn more about these two categories below: The Healthcare & Pharmaceutical Supply Chain Excellence Award – Private Sector This award looks to recognize techniques, projects…

    Read More
  8. Q&A with LATAM Medtech Leaders

    Steve Scalia, president of Tanner Pharma Group, was recently interview by Julio Martinez-Clark, founder and producer of the LATAM MedTech Leaders podcast series and CEO of Bioaccess. TannerLAC, a division of Tanner Pharma, provides pharmaceutical, biotech and healthcare companies with a single partner for the licensing, registration and commercialization of specialty pharmaceuticals, supplements and devices…

    Read More
  9. Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program

    SUZHOU, China and ROCKVILLE, Md. and CHARLOTTE, N.C./PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Tanner Pharma Group (“Tanner Pharma”), a global pharmaceutical services provider of specialty access solutions, have jointly launched an innovative Named Patient Program (NPP) for olverembatinib. This collaboration will allow access to Ascentage Pharma’s novel…

    Read More
  10. Increasing the Efficiency of Clinical Trials

    In this interview, Georg Schulz, EVP of Clinical Services & Senior Director of Corporate Development at Tanner Pharma Group speaks with The Medicine Maker about increasing the efficiency of clinical trials. He also offers his perspective on the trends and challenges affecting clinical trials, including the growing prevalence of digital and decentralized trials and COVID-19…

    Read More
  11. Increasing cancer treatment access in low and middle-income countries

    Originally featured on Pharmaceutical Technology. Low and middle-income countries typically have lower survival rates from cancer due to a lack of treatments, diagnosis, and support services. These issues are intensified for those living in remote communities. We learn more about Tanner’s partnership with The Max Foundation and how together the organizations have been able to deliver…

    Read More
  12. Navigating registration and commercialization challenges in Latin America

    Originally featured on Pharmaceutical Technology. Supplying medical products to Latin America presents a range of challenges. From registration requirements to logistics, supply maintenance and promotion, the complexities are further exacerbated by country-specific regulations, politics, healthcare systems, and more. Tanner Pharma recognized these challenges and started the TannerLAC division over 20 years ago to serve as a…

    Read More
  13. Tanner Pharma Group to Distribute Novel Diagnostic Test in Latin America

    TannerLAC UK Limited (“TannerLAC”), a part of Tanner Pharma Group, and Epimune Diagnostics (“Epimune”), a molecular diagnostic company, recently partnered to distribute the innovative diagnostic test, i.Mune TBNK®, in Latin America. i.Mune TBNK® is an IVD product that quantifies CD3+, CD4+, CD8+ T-, B- and NK lymphocytes in fresh blood or a dried blood spot…

    Read More
  14. Tanner Pharma Group Directors to Key International Healthcare Conferences

    Directors from Tanner Pharma Group will attend key international healthcare conferences in the coming weeks. Connect with our team members directly or via conference platforms to schedule meetings. We look forward to meeting with you. 29 – 30 November 2022 | Boston, MA, USA Tanner Pharma Attendees: 29 – 30 November 2022 | Boston, MA,…

    Read More
  15. Managed access programs explained with TannerMAP

    Tanner’s Managed Access Program (MAP) division specializes in increasing access to life-saving treatments for patients who would otherwise be unable to access them, either via pre-approval access programs or global donation programs. TannerMAP also develops and delivers access programs for specific medicines from manufacturer partners. TannerMAP focuses on providing access to medicines that are commercialized…

    Read More
  16. Crisis response: meeting urgent demand for PPE and tests in the pandemic

    Originally featured on Pharmaceutical Technology. As Covid-19 swept across the world, Tanner Pharma Group started receiving near-insurmountable requests from multiple industries for testing kits and PPE. We find out how the company met demand through the development of a dedicated subdivision, TannerGMS, and learn what the future holds for diagnostics and PPE as we emerge from…

    Read More
  17. Partnering to Respond to a Possible Nuclear Threat

    Originally posted on May 25, 2022 on PharmaceuticalExecutive.com. Steve Scalia, Bob Mulroy, John L. McManus Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity. In early March, an explosion at Ukraine’s Zaporizhzhia nuclear power plant after intense Russian shelling had the world…

    Read More
  18. Birmingham Biotech and Tanner Pharma Group Enter Distribution Partnership for Innovative Nasal Spray in Latin America

    Birmingham, UK, 31st May 2022 / Sciad Newswire / Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and TannerLAC UK Limited (“TannerLAC”), a part of Tanner Pharma Group, have entered into a license agreement for the distribution of Norizite™ Nasal Spray in Latin America. TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner…

    Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.